» Articles » PMID: 23305422

Postnatally-transmitted HIV-1 Envelope Variants Have Similar Neutralization-sensitivity and Function to That of Nontransmitted Breast Milk Variants

Abstract

Background: Breastfeeding is a leading cause of infant HIV-1 infection in the developing world, yet only a minority of infants exposed to HIV-1 via breastfeeding become infected. As a genetic bottleneck severely restricts the number of postnatally-transmitted variants, genetic or phenotypic properties of the virus Envelope (Env) could be important for the establishment of infant infection. We examined the efficiency of virologic functions required for initiation of infection in the gastrointestinal tract and the neutralization sensitivity of HIV-1 Env variants isolated from milk of three postnatally-transmitting mothers (n = 13 viruses), five clinically-matched nontransmitting mothers (n = 16 viruses), and seven postnatally-infected infants (n = 7 postnatally-transmitted/founder (T/F) viruses).

Results: There was no difference in the efficiency of epithelial cell interactions between Env virus variants from the breast milk of transmitting and nontransmitting mothers. Moreover, there was similar efficiency of DC-mediated trans-infection, CCR5-usage, target cell fusion, and infectivity between HIV-1 Env-pseudoviruses from nontransmitting mothers and postnatal T/F viruses. Milk Env-pseudoviruses were generally sensitive to neutralization by autologous maternal plasma and resistant to breast milk neutralization. Infant T/F Env-pseudoviruses were equally sensitive to neutralization by broadly-neutralizing monoclonal and polyclonal antibodies as compared to nontransmitted breast milk Env variants.

Conclusion: Postnatally-T/F Env variants do not appear to possess a superior ability to interact with and cross a mucosal barrier or an exceptional resistance to neutralization that define their capability to initiate infection across the infant gastrointestinal tract in the setting of preexisting maternal antibodies.

Citing Articles

A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions.

Dankwa S, Kosman C, Dennis M, Giorgi E, Vuong K, Pahountis I PLoS One. 2024; 19(11):e0312411.

PMID: 39527587 PMC: 11554116. DOI: 10.1371/journal.pone.0312411.


Viruses and Human Milk: Transmission or Protection?.

Francese R, Peila C, Donalisio M, Lamberti C, Cirrincione S, Colombi N Adv Nutr. 2023; 14(6):1389-1415.

PMID: 37604306 PMC: 10721544. DOI: 10.1016/j.advnut.2023.08.007.


Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.

Tu J, Kumar A, Giorgi E, Eudailey J, LaBranche C, Martinez D J Virol. 2022; 96(11):e0023122.

PMID: 35536018 PMC: 9175633. DOI: 10.1128/jvi.00231-22.


Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.

Kumar A, Giorgi E, Tu J, Martinez D, Eudailey J, Mengual M PLoS Pathog. 2021; 17(4):e1009478.

PMID: 33798244 PMC: 8055002. DOI: 10.1371/journal.ppat.1009478.


HIV-1 Entry and Prospects for Protecting against Infection.

Bruxelle J, Trattnig N, Mureithi M, Landais E, Pantophlet R Microorganisms. 2021; 9(2).

PMID: 33499233 PMC: 7911371. DOI: 10.3390/microorganisms9020228.


References
1.
Parrish N, Wilen C, Banks L, Iyer S, Pfaff J, Salazar-Gonzalez J . Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathog. 2012; 8(5):e1002686. PMC: 3364951. DOI: 10.1371/journal.ppat.1002686. View

2.
van de Perre P, Simonon A, Hitimana D, Dabis F, Msellati P, Mukamabano B . Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet. 1993; 341(8850):914-8. DOI: 10.1016/0140-6736(93)91210-d. View

3.
Lawless M, Barney S, Guthrie K, Bucy T, Petteway Jr S, Merutka G . HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry. 1996; 35(42):13697-708. DOI: 10.1021/bi9606962. View

4.
Hocini H, Belec L, Iscaki S, Garin B, Pillot J, Becquart P . High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses. 1997; 13(14):1179-85. DOI: 10.1089/aid.1997.13.1179. View

5.
Holla A, Skerra A . Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin. Protein Eng Des Sel. 2011; 24(9):659-69. DOI: 10.1093/protein/gzr016. View